The International Society for Pharmacoeconomics and Outcomes Research (ISPOR 2025)
Poster
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR 2025)
13-16 May 2025. Montreal, QC, Canada.
Expected vs. Observed Mortality Rates, Expressed As Number Needed to Treat, From a Phase 3 Clinical Trial Program of Patients With Hyperphagia and Prader-Willi Syndrome Treated With Diazoxide Choline Extended Release (DCCR)
Cowen N, Gandhi R, Yin S, et al.
Poster
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR 2025)
13-16 May 2025. Montreal, QC, Canada.
The Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A Cross-Sectional Examination of Emergency Department Visits and Inpatient Stays in U.S. Claims
Gandhi R, Kwong M, Guo M, et al.
